Vignesh Packiam, MD

MD

Disclosure information not submitted.

Presentation(s):

• PD26-07: Sequential Endoluminal Cabazitaxel and Gemcitabine with Pembrolizumab For Docetaxel-Unresponsive Non-muscle Invasive Urothelial Carcinoma of the Upper and Lower Urinary Tracts

  Saturday, May 14, 2022
  2:00 PM – 2:10 PM